Literature DB >> 9348446

Six month clinical evaluation of a biomimetic hydrogel contact lens.

G Young1, R Bowers, B Hall, M Port.   

Abstract

PURPOSE: We performed a six-month, comparative, contralateral/bilateral study to assess the clinical performance of the Proclear contact lens, which is manufactured from a novel, biomimetic, 59% water content, hydrogel material (Omafilcon A). Omafilcon A is a hydrogel polymer and is based on a new biomimetic approach to the design of biomaterials for biomedical applications. The polymer incorporates a synthetic analogue of the phosphorylcholine (PC) headgroup, an important component found in all human cells.
METHODS: Forty-two subjects were fit with the Proclear lens for 6 months of daily wear; 20 subjects wore a Proclear lens in one eye and a Permaflex lens in the fellow as a control, while 22 subjects wore Proclear lenses in both eyes. A one-step hydrogen peroxide system was used for disinfection and no protein remover was used.
RESULTS: No subject was required to withdraw due to unacceptable physiological findings with the Proclear lens. At the 3-month visit, corneal staining was present in 33% of the Proclear eyes compared to 72% of the Permaflex-wearing eyes. At one month, the Proclear lens was graded significantly more comfortable than the Permaflex lens (P < 0.01), and all 11 of the subjects who expressed a preference did so in favor of the Proclear lens. Overall, the fitting characteristics and visual performance of the Proclear lens did not appear to vary during the study. Spectrofluorimetric analysis of worn lenses confirm that Proclear showed minimal protein and lipid spoliation, which was found to be independent of wear time and subject variations. In contrast, despite the use of a surfactant cleaner, Permaflex lenses showed measurable and significant levels of lipid spoilation. Despite significant differences in average mean thicknesses and the level of bulk water in the lenses, in vivo dehydration of the Proclear lens was significantly lower than that of the Permaflex lens.
CONCLUSIONS: The results of this study have confirmed the viability of biomimetic PC-hydrogels in contact lens applications. In vivo and in vitro analyses tended to confirm that Omafilcon A has a number of superior material attributes, as compared to conventional hydrogels when used in contact lens applications.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348446

Source DB:  PubMed          Journal:  CLAO J        ISSN: 0733-8902


  6 in total

Review 1.  Closer to nature: new biomaterials and tissue engineering in ophthalmology.

Authors:  B Allan
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Clinical Performance of Samfilcon A, a Unique Silicone Hydrogel Lens, on a 7-Day Extended Wear Basis.

Authors:  William Reindel; Gary Mosehauer; Marjorie Rah; Howard Proskin; Robert Steffen
Journal:  Clin Ophthalmol       Date:  2020-10-23

3.  Evaluation of Sodium Hyaluronate Lubricating Drops Used before Insertion of Contact Lenses on Symptomatology, Severity, and Intensity of Ocular Dryness.

Authors:  Langis Michaud; Benoît Frenette
Journal:  ISRN Ophthalmol       Date:  2012-09-02

4.  Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice.

Authors:  Jing Wen; Di Wu; Meng Qin; Chaoyong Liu; Lan Wang; Duo Xu; Harry V Vinters; Yang Liu; Emiko Kranz; Xin Guan; Guibo Sun; Xiaobo Sun; YooJin Lee; Otoniel Martinez-Maza; Daniel Widney; Yunfeng Lu; Irvin S Y Chen; Masakazu Kamata
Journal:  Nat Biomed Eng       Date:  2019-08-05       Impact factor: 25.671

5.  Subjective Comparison of Pre-Lens Tear Film Stability of Daily Disposable Contact Lenses Using Ring Mire Projection.

Authors:  Christiane Müller; Sebastian Marx; Julia Wittekind; Wolfgang Sickenberger
Journal:  Clin Optom (Auckl)       Date:  2020-02-28

6.  Enhanced Delivery of Rituximab Into Brain and Lymph Nodes Using Timed-Release Nanocapsules in Non-Human Primates.

Authors:  Meng Qin; Lan Wang; Di Wu; Christopher K Williams; Duo Xu; Emiko Kranz; Qi Guo; Jiaoqiong Guan; Harry V Vinters; YooJin Lee; Yiming Xie; Yun Luo; Guibo Sun; Xiaobo Sun; Zhanlong He; Yunfeng Lu; Masakazu Kamata; Jing Wen; Irvin S Y Chen
Journal:  Front Immunol       Date:  2020-01-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.